Galt Phranchise™ System is proud to announce its expansion into New York with the launch of 6 new franchise territories across the state.
NEW YORK, NY, UNITED STATES, January 20, 2026 /EINPresswire.com/ — Galt Phranchise™ System, the pharmaceutical franchise model redefining community-based healthcare, is proud to announce its expansion into New York with the launch of 6 new franchise territories across the state.
This strategic growth marks a significant milestone in Galt’s mission to empower local entrepreneurs and healthcare professionals to deliver high-quality pharmaceutical care directly within their communities. With this expansion, Galt continues to lower barriers to entry into the highly regulated pharmaceutical industry, enabling compliant, patient-centric enterprises that serve neighborhoods with authenticity and care.
“We’re thrilled to welcome these new franchisees into the Galt family,” said Mike Harley, Chief Franchise Officer of Galt Phranchise ™ System. “Their commitment and passion to community health and entrepreneurial spirit is in alignment with our vision of transforming pharmaceutical access through local ownership.”
Galt Phranchise™ System continues to enhance the traditional pharmaceutical model by offering a scalable, franchise-based approach that prioritizes community engagement, regulatory compliance, and sustainable growth. With this expansion, Galt is deepening its footprint in New York, bringing its FDA-approved prescription portfolio and educational outreach to Brooklyn, while expanding access to innovative treatments and building strong partnerships in Queens.
About Galt Phranchise™ System (“GPS”)
Founded in 2018, Galt Phranchise™ System is redefining pharmaceutical distribution by creating a unique franchise opportunity for entrepreneurs to own and operate local pharmaceutical sales enterprises. The GPS model empowers individuals to promote health-related products through education, outreach, and relationships—while providing superior support to navigate the complexities of the pharmaceutical industry.
For media inquiries or franchise opportunities, please visit GaltFranchise.com or call 855-965-2783.
Tucker Bedingfield
Galt Companies
+1 855-965-2783
email us here
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
